- Supported exchanges /
- TWO /
- 4120.TWO
Orient Europharma Co Ltd (4120 TWO) stock market data APIs
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name. In addition, the company offers essences, creams, lotions, eye creams, facial treatment toners, and skin repairing essences under the AGLab name; skincare oils, body lotions, and dry skin gels under the Bio-Oil name; and children skincare products under the Mister Baby brand, as well as operates ISISPHARMA, a dermatology laboratory specialized in the development and distribution of dermo-cosmetic products. Further, it engages in the research and development of Multikine, an immunotherapy drug for head and neck cancer, which is in Phase III clinical study; NC-6004, a platinum-based micelle chemotherapeutic drug that is in Phase III clinical study; ASC-J9, a molecular chemical entity drug that has completed Phase IIb clinical study for androgen receptor degradation; and 2ccPA, a derivative of phospholipid to patients with symptomatic osteoarthritis of the knee, which is in Phase I clinical trail. Orient EuroPharma Co., Ltd. was founded in 1982 and is based in Taipei, Taiwan.
Orient Europharma Co Ltd Financial Data Overview
| 48.7 | |
| 48.05 | |
| - | |
| 48.9 | |
| 48 | |
| 35.966-54.782 | |
| 4 242 M | |
| 29.2814 | |
| 86 747 K | |
| 4 499 M | |
| 0.62 | |
| 0.0207 | |
| 0.41 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Orient Europharma Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 499 M
- EBITDA 321 M
- Earnings Per Share 1.67
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Orient Europharma Co Ltd Earnings via APIs
- Latest Release 2019-08-16
- EPS/Forecast 0.63
Get Orient Europharma Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
